NCT02161146 - AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

June 4, 2014

Primary Completion Date

December 20, 2014

Study Completion Date

December 20, 2014

Conditions

Conjunctivitis, Allergic

Interventions

DRUG

AGN-229666

One drop of AGN-229666 in the eye on Days 1 and 15.

DRUG

Vehicle to AGN-229666

One drop of Vehicle to AGN-229666 in the eye on Days 1 and 15.

DRUG

Olopatadine

One drop of olopatadine in the eye on Days 1 and 15.

Trial Locations (1)

Tokyo